Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2004 1
2005 5
2006 10
2007 9
2008 13
2009 9
2010 10
2011 11
2012 9
2013 13
2014 9
2015 16
2016 19
2017 25
2018 11
2019 7
2020 8
2021 4
2022 7
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

190 results

Results by year

Filters applied: . Clear all
Page 1
Combined vemurafenib and cobimetinib in BRAF-mutated melanoma.
Larkin J, Ascierto PA, Dréno B, Atkinson V, Liszkay G, Maio M, Mandalà M, Demidov L, Stroyakovskiy D, Thomas L, de la Cruz-Merino L, Dutriaux C, Garbe C, Sovak MA, Chang I, Choong N, Hack SP, McArthur GA, Ribas A. Larkin J, et al. Among authors: thomas l. N Engl J Med. 2014 Nov 13;371(20):1867-76. doi: 10.1056/NEJMoa1408868. Epub 2014 Sep 29. N Engl J Med. 2014. PMID: 25265494 Free article. Clinical Trial.
Ipilimumab plus dacarbazine for previously untreated metastatic melanoma.
Robert C, Thomas L, Bondarenko I, O'Day S, Weber J, Garbe C, Lebbe C, Baurain JF, Testori A, Grob JJ, Davidson N, Richards J, Maio M, Hauschild A, Miller WH Jr, Gascon P, Lotem M, Harmankaya K, Ibrahim R, Francis S, Chen TT, Humphrey R, Hoos A, Wolchok JD. Robert C, et al. Among authors: thomas l. N Engl J Med. 2011 Jun 30;364(26):2517-26. doi: 10.1056/NEJMoa1104621. Epub 2011 Jun 5. N Engl J Med. 2011. PMID: 21639810 Free article. Clinical Trial.
Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial.
Davies MA, Saiag P, Robert C, Grob JJ, Flaherty KT, Arance A, Chiarion-Sileni V, Thomas L, Lesimple T, Mortier L, Moschos SJ, Hogg D, Márquez-Rodas I, Del Vecchio M, Lebbé C, Meyer N, Zhang Y, Huang Y, Mookerjee B, Long GV. Davies MA, et al. Among authors: thomas l. Lancet Oncol. 2017 Jul;18(7):863-873. doi: 10.1016/S1470-2045(17)30429-1. Epub 2017 Jun 4. Lancet Oncol. 2017. PMID: 28592387 Free PMC article. Clinical Trial.
Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial.
Dummer R, Schadendorf D, Ascierto PA, Arance A, Dutriaux C, Di Giacomo AM, Rutkowski P, Del Vecchio M, Gutzmer R, Mandala M, Thomas L, Demidov L, Garbe C, Hogg D, Liszkay G, Queirolo P, Wasserman E, Ford J, Weill M, Sirulnik LA, Jehl V, Bozón V, Long GV, Flaherty K. Dummer R, et al. Among authors: thomas l. Lancet Oncol. 2017 Apr;18(4):435-445. doi: 10.1016/S1470-2045(17)30180-8. Epub 2017 Mar 9. Lancet Oncol. 2017. PMID: 28284557 Clinical Trial.
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.
Weber JS, D'Angelo SP, Minor D, Hodi FS, Gutzmer R, Neyns B, Hoeller C, Khushalani NI, Miller WH Jr, Lao CD, Linette GP, Thomas L, Lorigan P, Grossmann KF, Hassel JC, Maio M, Sznol M, Ascierto PA, Mohr P, Chmielowski B, Bryce A, Svane IM, Grob JJ, Krackhardt AM, Horak C, Lambert A, Yang AS, Larkin J. Weber JS, et al. Among authors: thomas l. Lancet Oncol. 2015 Apr;16(4):375-84. doi: 10.1016/S1470-2045(15)70076-8. Epub 2015 Mar 18. Lancet Oncol. 2015. PMID: 25795410 Clinical Trial.
Cobimetinib and vemurafenib for the treatment of melanoma.
Boespflug A, Thomas L. Boespflug A, et al. Among authors: thomas l. Expert Opin Pharmacother. 2016;17(7):1005-11. doi: 10.1517/14656566.2016.1168806. Expert Opin Pharmacother. 2016. PMID: 26999478 Review.
Vemurafenib-induced panniculitis.
Villani AP, Zaharia D, Dalle S, Depaepe L, Balme B, Thomas L. Villani AP, et al. Among authors: thomas l. Eur J Dermatol. 2013 Apr 1;23(2):258-60. doi: 10.1684/ejd.2013.1991. Eur J Dermatol. 2013. PMID: 23567624 No abstract available.
[Unusual lymphangitis].
Biancheri D, Depaepe L, Durupt F, Thomas L, Berger F, Balme B. Biancheri D, et al. Among authors: thomas l. Ann Pathol. 2015 Apr;35(2):186-8. doi: 10.1016/j.annpat.2015.01.002. Epub 2015 Mar 9. Ann Pathol. 2015. PMID: 25765137 French. No abstract available.
Special locations dermoscopy: facial, acral, and nail.
Thomas L, Phan A, Pralong P, Poulalhon N, Debarbieux S, Dalle S. Thomas L, et al. Dermatol Clin. 2013 Oct;31(4):615-24, ix. doi: 10.1016/j.det.2013.06.006. Epub 2013 Aug 23. Dermatol Clin. 2013. PMID: 24075549 Review.
Primary cutaneous marginal zone lymphoma.
Dalle S, Thomas L, Balme B, Dumontet C, Thieblemont C. Dalle S, et al. Among authors: thomas l. Crit Rev Oncol Hematol. 2010 Jun;74(3):156-62. doi: 10.1016/j.critrevonc.2009.09.003. Epub 2009 Oct 12. Crit Rev Oncol Hematol. 2010. PMID: 19819717 Review.
190 results